RCEL - AVITA Medical, Inc.
IEX Last Trade
13.67
0.565 4.133%
Share volume: 7,865
Last Updated: Fri 27 Dec 2024 02:30:18 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$13.10
0.57
4.31%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-02-23 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-02-22 | 2024-05-13 | |
| Total revenue | 8.335 M | 9.092 M | 9.455 M | 10.550 M | 11.753 M | 13.645 M | 14.195 M | 11.104 M | |
| Cost of revenue | 1.386 M | 1.530 M | 1.347 M | 1.667 M | 2.204 M | 2.113 M | 1.796 M | 1.513 M | |
| Gross profit | 6.949 M | 7.562 M | 8.108 M | 8.883 M | 9.549 M | 11.532 M | 12.399 M | 9.591 M | |
| 8.82% | 7.22% | 9.56% | 7.50% | 20.77% | 7.52% | -22.65% | |||
| Operating expenses | 13.862 M | 14.214 M | 15.042 M | 19.421 M | 21.244 M | 21.050 M | 24.731 M | 26.797 M | |
| Selling general and admin | 10.803 M | 10.415 M | 11.663 M | 14.835 M | 16.168 M | 16.656 M | 17.966 M | 21.603 M | |
| Research and development | 3.059 M | 3.799 M | 3.379 M | 4.586 M | 5.076 M | 4.394 M | 6.765 M | 5.194 M | |
| Total expenses | 15.248 M | 15.744 M | 16.389 M | 21.088 M | 23.448 M | 23.163 M | 26.527 M | 28.310 M | |
| 3.25% | 4.10% | 28.67% | 11.19% | -1.22% | 14.52% | 6.72% | |||
| Operating income | -6.913 M | -6.652 M | -6.934 M | -10.538 M | -11.695 M | -9.518 M | -12.332 M | -17.206 M | |
| Ebit | -6.362 M | -5.748 M | -5.908 M | -9.911 M | -11.165 M | -9.306 M | -12.273 M | -17.206 M | |
| Pretax income | -6.257 M | -5.584 M | -5.329 M | -9.190 M | -10.371 M | -8.701 M | -7.053 M | -18.628 M | |
| -10.76% | -4.57% | 72.45% | 12.85% | -16.10% | -18.94% | 164.11% | |||
| Income tax | 4.000 K | 4.000 K | 24.000 K | 30.000 K | 13.000 K | 11.000 K | 12.000 K | 30.000 K | |
| Net income basic | -6.261 M | -5.588 M | -5.353 M | -9.220 M | -10.384 M | -8.712 M | -7.065 M | -18.658 M | |
| 10.75% | 4.21% | -72.24% | -12.62% | 16.10% | 18.90% | -164.09% | |||
| Net income | -6.261 M | -5.588 M | -5.353 M | -9.220 M | -10.384 M | -8.712 M | -7.065 M | -18.658 M | |
| 10.75% | 4.21% | -72.24% | -12.62% | 16.10% | 18.90% | -164.09% |